Fig. 1From: Synthesis of novel mono- and bis-pyrazolylthiazole derivatives as anti-liver cancer agents through EGFR/HER2 target inhibitionExamples of naphthalene- and (bis-aryl)propylenedioxy-based marketed DrugsBack to article page
